BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang ZB, Xu J. Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery. Vaccines (Basel) 2020;8:E128. [PMID: 32183209 DOI: 10.3390/vaccines8010128] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Feng Y, Fan J, Wu D, Liu Q, Li H, Zhang X, Li S, Tang F, Liu Z, Zhang L, Feng H. DEC-205 receptor targeted poly(lactic-co-glycolic acid) nanoparticles containing Eucommia ulmoides polysaccharide enhances the immune response of foot-and-mouth disease vaccine in mice. Int J Biol Macromol 2023;227:576-89. [PMID: 36549613 DOI: 10.1016/j.ijbiomac.2022.12.158] [Reference Citation Analysis]
2 Chung YH, Volckaert BA, Steinmetz NF. Development of a Modular NTA:His Tag Viral Vaccine for Co-delivery of Antigen and Adjuvant. Bioconjug Chem 2023;34:269-78. [PMID: 36608270 DOI: 10.1021/acs.bioconjchem.2c00601] [Reference Citation Analysis]
3 Chen H, Li Y, Li L, Yang Z, Wen Z, Liu L, Liu H, Chen Y. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections. Acta Biomater 2022:S1742-7061(22)00852-2. [PMID: 36572250 DOI: 10.1016/j.actbio.2022.12.042] [Reference Citation Analysis]
4 Zagorski K, Pandey K, Rajaiah R, Olwenyi OA, Bade AN, Acharya A, Johnston M, Filliaux S, Lyubchenko YL, Byrareddy SN. Modular nanoarray vaccine for SARS-CoV-2. Nanomedicine: Nanotechnology, Biology and Medicine 2022;46:102604. [DOI: 10.1016/j.nano.2022.102604] [Reference Citation Analysis]
5 Wang Z, Shan P, Li S, Wei D, Zhang Z, Hao S, Li W, Wang X, Xu J. Artificial Nanolipid Droplets with Monolayer Lecithin Membranes and Vitamin E Cores as Vaccine Adjuvants. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c03222] [Reference Citation Analysis]
6 Patel U, Rathnayake K, Hunt EC, Singh N. Role of Nanomaterials in COVID-19 Prevention, Diagnostics, Therapeutics, and Vaccine Development. JNT 2022;3:151-176. [DOI: 10.3390/jnt3040011] [Reference Citation Analysis]
7 Nazeam JA, Singab ANB. Immunostimulant plant proteins: Potential candidates as vaccine adjuvants. Phytother Res 2022;36:4345-60. [PMID: 36128599 DOI: 10.1002/ptr.7624] [Reference Citation Analysis]
8 Li W, Li J, Dai X, Liu M, Khalique A, Wang Z, Zeng Y, Zhang D, Ni X, Zeng D, Jing B, Pan K. Surface Display of porcine circovirus type 2 antigen protein cap on the spores of bacillus subtilis 168: An effective mucosal vaccine candidate. Front Immunol 2022;13:1007202. [DOI: 10.3389/fimmu.2022.1007202] [Reference Citation Analysis]
9 Hoover AR, More S, Liu K, West CL, Valero TI, Yu N, Villalva C, Kumar A, Alleruzzo L, Lam SSK, Hode T, Papin JF, Chen WR. A novel biopolymer for mucosal adjuvant against respiratory pathogens.. [DOI: 10.1101/2022.09.07.506979] [Reference Citation Analysis]
10 Díaz-dinamarca DA, Salazar ML, Castillo BN, Manubens A, Vasquez AE, Salazar F, Becker MI. Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities. Pharmaceutics 2022;14:1671. [DOI: 10.3390/pharmaceutics14081671] [Reference Citation Analysis]
11 Du G, Qin M, Sun X. Recent progress in application of nanovaccines for enhancing mucosal immune responses. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.010] [Reference Citation Analysis]
12 Kondakova OA, Evtushenko EA, Baranov OA, Nikitin NA, Karpova OV. Structurally Modified Plant Viruses and Bacteriophages with Helical Structure. Properties and Applications. Biochemistry Moscow 2022;87:548-558. [DOI: 10.1134/s0006297922060062] [Reference Citation Analysis]
13 Huang Z, Callmann CE, Wang S, Vasher MK, Evangelopoulos M, Petrosko SH, Mirkin CA. Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy. ACS Cent Sci . [DOI: 10.1021/acscentsci.2c00227] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xie D, Niu Y, Mu R, Campos de Souza S, Yin X, Dong L, Wang C. A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier. Front Chem 2022;10:864206. [DOI: 10.3389/fchem.2022.864206] [Reference Citation Analysis]
15 Nazarizadeh A, Staudacher AH, Wittwer NL, Turnbull T, Brown MP, Kempson I. Aluminium Nanoparticles as Efficient Adjuvants Compared to Their Microparticle Counterparts: Current Progress and Perspectives. IJMS 2022;23:4707. [DOI: 10.3390/ijms23094707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ghosh C, Priegue P, Leelayuwapan H, Fuchsberger FF, Rademacher C, Seeberger PH. Synthetic Glyconanoparticles Modulate Innate Immunity but Not the Complement System. ACS Appl Bio Mater . [DOI: 10.1021/acsabm.2c00026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Skwarczynski M. Editorial: Advances in Vaccine Delivery: Adjuvants, Carriers, Formulations, and Routes. Front Pharmacol 2022;13:857792. [PMID: 35222053 DOI: 10.3389/fphar.2022.857792] [Reference Citation Analysis]
18 Yang J, Tseng J, Yu G, Luo Y, Huang CF, Hong Y, Chuang T. Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 2022;14:423. [DOI: 10.3390/pharmaceutics14020423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Alphandéry E. Nano dimensions/adjuvants in COVID-19 vaccines. J Mater Chem B 2022. [PMID: 35166754 DOI: 10.1039/d1tb02408f] [Reference Citation Analysis]
20 Mangla B, Javed S, Sultan MH, Ahsan W, Aggarwal G, Kohli K. Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit. Front Pharmacol 2021;12:757761. [PMID: 35087403 DOI: 10.3389/fphar.2021.757761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Brohlin OR, Ehrman RN, Herbert FC, Wijesundara YH, Raja A, Shahrivarkevishahi A, Diwakara SD, Smaldone RA, Gassensmith JJ. Zeolitic Imidazolate Framework Nanoencapsulation of CpG for Stabilization and Enhancement of Immunoadjuvancy. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.1c03555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Debnath SK, Srivastava R. Potential Application of Bionanoparticles to Treat Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Front Nanotechnol 2022;3:813847. [DOI: 10.3389/fnano.2021.813847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Öztürk ME, Yirün A, Erdemli-köse SB, Balcı-özyurt A, Çakır DA, Oral D, Erkekoğlu P. Evaluation of the toxic effects of thimerosal and/or aluminum hydroxide in SH-SY5Y cell line. Hum Exp Toxicol 2022;41:096032712211362. [DOI: 10.1177/09603271221136206] [Reference Citation Analysis]
24 Farouk IA, Low ZY, Puniyamurti A, Zabidi NZ, Amin MKA, Lal SK. Genomic Approaches for Drug Repositioning. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-9232-1_5] [Reference Citation Analysis]
25 Koo BI, Jin SM, Kim H, Lee DJ, Lee E, Nam YS. Conjugation-Free Multilamellar Protein-Lipid Hybrid Vesicles for Multifaceted Immune Responses. Adv Healthc Mater 2021;10:e2101239. [PMID: 34467659 DOI: 10.1002/adhm.202101239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Cattel L, Giordano S, Traina S, Lupia T, Corcione S, Angelone L, La Valle G, De Rosa FG, Cattel F. Vaccine development and technology for SARS-CoV-2: Current insight. J Med Virol 2021. [PMID: 34713912 DOI: 10.1002/jmv.27425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Ahn YH, Chathuranga WAG, Shim YJ, Haluwana DK, Kim EH, Yoon IJ, Lim YT, Shin SH, Jo H, Hwang SY, Kim HM, Lee MJ, Park JH, Yoo SS, Lee JS. The Potential Adjuvanticity of CAvant®SOE for Foot-and-Mouth Disease Vaccine. Vaccines (Basel) 2021;9:1091. [PMID: 34696199 DOI: 10.3390/vaccines9101091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Caudill C, Perry JL, Iliadis K, Tessema AT, Lee BJ, Mecham BS, Tian S, DeSimone JM. Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity. Proc Natl Acad Sci U S A 2021;118:e2102595118. [PMID: 34551974 DOI: 10.1073/pnas.2102595118] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
29 Ritzau-Jost J, Hutloff A. T Cell/B Cell Interactions in the Establishment of Protective Immunity. Vaccines (Basel) 2021;9:1074. [PMID: 34696182 DOI: 10.3390/vaccines9101074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Basu P, Saha N, Saha T, Saha P. Polymeric hydrogel based systems for vaccine delivery: A review. Polymer 2021;230:124088. [DOI: 10.1016/j.polymer.2021.124088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
31 Chatzikleanthous D, O'Hagan DT, Adamo R. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Mol Pharm 2021;18:2867-88. [PMID: 34264684 DOI: 10.1021/acs.molpharmaceut.1c00447] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
32 Khrustalev VV. The PentaFOLD 3.0 Algorithm for the Selection of Stable Elements of Secondary Structure to be Included in Vaccine Peptides. Protein Pept Lett 2021;28:573-88. [PMID: 33172366 DOI: 10.2174/0929866527666201110123851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Donninger H, Li C, Eaton JW, Yaddanapudi K. Cancer Vaccines: Promising Therapeutics or an Unattainable Dream. Vaccines (Basel) 2021;9:668. [PMID: 34207062 DOI: 10.3390/vaccines9060668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
34 Wepner L, Färber HA, Weber A, Jaensch A, Keilig L, Heuser FA, Bourauel CP. [Aluminium release of glitter particles in removable orthodontic appliances]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021;64:856-61. [PMID: 34115152 DOI: 10.1007/s00103-021-03361-6] [Reference Citation Analysis]
35 Huang X, Lu Y, Guo M, Du S, Han N. Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view. Theranostics 2021;11:7546-69. [PMID: 34158866 DOI: 10.7150/thno.56482] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
36 Yang JI, Kim KH. Fusion of Streptococcus iniae α-enolase to IMX313 enhanced antibody titer and survival rate in olive flounder (Paralichthys olivaceus). Fish Shellfish Immunol 2021;115:70-4. [PMID: 34089887 DOI: 10.1016/j.fsi.2021.05.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Jazayeri SD, Lim HX, Shameli K, Yeap SK, Poh CL. Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases. Front Pharmacol 2021;12:682286. [PMID: 34149426 DOI: 10.3389/fphar.2021.682286] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
38 Lu L, Duong VT, Shalash AO, Skwarczynski M, Toth I. Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines. Vaccines (Basel) 2021;9:563. [PMID: 34071482 DOI: 10.3390/vaccines9060563] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
39 Jafari E, Mahmoodi S. Design, expression, and purification of a multi-epitope vaccine against Helicobacter Pylori based on Melittin as an adjuvant. Microb Pathog 2021;157:104970. [PMID: 34022362 DOI: 10.1016/j.micpath.2021.104970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
40 Veenstra KA, Wang T, Russell KS, Tubbs L, Ben Arous J, Secombes CJ. Montanide™ ISA 763A VG and ISA 761 VG induce different immune pathway responses in rainbow trout (Oncorhynchus mykiss) when used as adjuvant for an Aeromonas salmonicida bacterin. Fish Shellfish Immunol 2021;114:171-83. [PMID: 33940174 DOI: 10.1016/j.fsi.2021.04.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Asadi K, Gholami A. Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review. Int J Biol Macromol 2021;182:648-58. [PMID: 33862071 DOI: 10.1016/j.ijbiomac.2021.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
42 Chen TH, Hu CC, Lee CW, Feng YM, Lin NS, Hsu YH. Stable Display of Artificially Long Foreign Antigens on Chimeric Bamboo mosaic virus Particles. Viruses 2021;13:572. [PMID: 33805417 DOI: 10.3390/v13040572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Petkar KC, Patil SM, Chavhan SS, Kaneko K, Sawant KK, Kunda NK, Saleem IY. An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics 2021;13:455. [PMID: 33801614 DOI: 10.3390/pharmaceutics13040455] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
44 Zarubova J, Zhang X, Hoffman T, Hasani-Sadrabadi MM, Li S. Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases. Matter 2021;4:1528-54. [PMID: 33723531 DOI: 10.1016/j.matt.2021.02.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
45 Cuzzubbo S, Mangsbo S, Nagarajan D, Habra K, Pockley AG, McArdle SEB. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Front Immunol 2020;11:615240. [PMID: 33679703 DOI: 10.3389/fimmu.2020.615240] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
46 Wang ZB, Shan P, Wei DQ, Hao SJ, Zhang Z, Li SX, Xu J. Optical Density Value and Ratio as Novel Indexes for Nanoemulsion Sterile Filtration Process Control or Characterization. J Pharm Sci 2021;110:2416-22. [PMID: 33387598 DOI: 10.1016/j.xphs.2020.12.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Adeagbo BA, Akinlalu AO, Phan T, Guderian J, Boukes G, Willenburg E, Fenner C, Bolaji OO, Fox CB. Controlled Covalent Conjugation of a Tuberculosis Subunit Antigen (ID93) to Liposome Improved In Vitro Th1-Type Cytokine Recall Responses in Human Whole Blood. ACS Omega 2020;5:31306-13. [PMID: 33324841 DOI: 10.1021/acsomega.0c04774] [Reference Citation Analysis]
48 Chung YH, Beiss V, Fiering SN, Steinmetz NF. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano 2020;14:12522-37. [PMID: 33034449 DOI: 10.1021/acsnano.0c07197] [Cited by in Crossref: 190] [Cited by in F6Publishing: 201] [Article Influence: 63.3] [Reference Citation Analysis]
49 Mignot E, Black S. Narcolepsy risk and COVID-19. J Clin Sleep Med 2020;16:1831-3. [PMID: 32621581 DOI: 10.5664/jcsm.8668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
50 GenÇ R, YakuboĞullari N, Nalbantsoy A, ÇÖven F, Bedİr E. Adjuvant potency of Astragaloside VII embedded cholesterol nanoparticles for H3N2 influenza vaccine. Turk J Biol 2020;44:304-14. [PMID: 33110368 DOI: 10.3906/biy-2003-49] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
51 Beijer E, Kraaijvanger R, Roodenburg C, Grutters JC, Meek B, Veltkamp M. Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype. Clin Exp Immunol 2021;203:115-24. [PMID: 32941653 DOI: 10.1111/cei.13519] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
52 Hanna R, Dalvi S, Sălăgean T, Bordea IR, Benedicenti S. Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review. Antioxidants (Basel) 2020;9:E875. [PMID: 32947974 DOI: 10.3390/antiox9090875] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
53 Araujo SC, Pereira LR, Alves RPS, Andreata-Santos R, Kanno AI, Ferreira LCS, Gonçalves VM. Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli. Vaccines (Basel) 2020;8:E492. [PMID: 32878023 DOI: 10.3390/vaccines8030492] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]